BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35235545)

  • 1. A Case of Gorlin-Goltz Syndrome Without the Characteristic Physical Features That Was Diagnosed After the Development of a Fifth Cancer.
    Katayama D; Inoue A; Kayatani R; Urabe K; Suzuki R; Takitani K; Yoshida M; Kato M; Ashida A
    J Pediatr Hematol Oncol; 2022 May; 44(4):e869-e871. PubMed ID: 35235545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gorlin-Goltz Syndrome - A Rare Case Entity in Young Child.
    Mondal S; Jain NK; Dutta A; Nishant ; Dutta A; Shil M; Sen S
    Prague Med Rep; 2024; 125(1):69-78. PubMed ID: 38470440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of calretinin in odontogenic keratocysts and basal cell carcinomas: A study of sporadic and Gorlin-Goltz syndrome-related cases.
    Cesinaro AM; Burtini G; Maiorana A; Rossi G; Migaldi M
    Ann Diagn Pathol; 2020 Apr; 45():151472. PubMed ID: 31982676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent medulloblastoma and cardiac fibroma: a rare presentation of Gorlin-Goltz syndrome.
    Alanazi R; Alkhaibary A; Alfaqawwy W; AlSufiani F; Ahmad N; Aljared T
    Childs Nerv Syst; 2023 Sep; 39(9):2499-2504. PubMed ID: 37160435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric leiomyoma in a child with Gorlin-Goltz syndrome: First pediatric case.
    Virgone C; Decker E; Mitton SG; Mansour S; Giuliani S
    Pediatr Int; 2016 Apr; 58(4):298-300. PubMed ID: 26567923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel PTCH1 gene mutation in a pediatric patient associated multiple keratocystic odontogenic tumors of the jaws and Gorlin-Goltz syndrome.
    Ozcan G; Balta B; Sekerci AE; Etoz OA; Martinuzzi C; Kara O; Pastorino L; Kocoglu F; Ulker O; Erdogan M
    Indian J Pathol Microbiol; 2016; 59(3):335-8. PubMed ID: 27510672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
    Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
    J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinoma arising in association with a maxillary keratocyst in a patient with Gorlin-Goltz syndrome. Report of a case.
    Lazaridou MN; Dimitrakopoulos I; Tilaveridis I; Iliopoulos C; Heva A
    Oral Maxillofac Surg; 2012 Mar; 16(1):127-31. PubMed ID: 21744042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and oral findings in an Afro-Brazilian family with Gorlin-Goltz syndrome: case series and literature review.
    da Silva Pierro VS; Marins MR; Borges de Oliveira RC; Cortezzi W; Janini ME; Maia LC
    Spec Care Dentist; 2015; 35(1):43-50. PubMed ID: 25039802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous recovery from a medulloblastoma by a female with Gorlin-Goltz syndrome.
    Su CW; Lin KL; Hou JW; Jung SM; Zen EC
    Pediatr Neurol; 2003 Mar; 28(3):231-4. PubMed ID: 12770681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell carcinoma of the eyelid associated with Gorlin-Goltz syndrome.
    Honavar SG; Shields JA; Shields CL; Eagle RC; Demirci H; Mahmood EZ
    Ophthalmology; 2001 Jun; 108(6):1115-23. PubMed ID: 11382639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumours and the occurrence of severe invasive basal cell carcinoma in first degree relatives with Gorlin syndrome.
    Evans DG; Birch JM; Orton CI
    Br J Neurosurg; 1991; 5(6):643-6. PubMed ID: 1772613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular manifestations in Gorlin-Goltz syndrome.
    Moramarco A; Himmelblau E; Miraglia E; Mallone F; Roberti V; Franzone F; Iacovino C; Giustini S; Lambiase A
    Orphanet J Rare Dis; 2019 Sep; 14(1):218. PubMed ID: 31533758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
    Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
    Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestations of Gorlin-Goltz syndrome.
    Larsen AK; Mikkelsen DB; Hertz JM; Bygum A
    Dan Med J; 2014 May; 61(5):A4829. PubMed ID: 24814739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gorlin-Goltz syndrome.
    Ljubenović M; Ljubenović D; Binić I; Jovanović D; Stanojević M
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Dec; 16(4):166-9. PubMed ID: 18204747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gorlin-Goltz syndrome without cutaneous manifestations.
    Singh RK; Mishra GV
    Pan Afr Med J; 2021; 39():239. PubMed ID: 34659612
    [No Abstract]   [Full Text] [Related]  

  • 18. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct non-clock-like signatures of the basal cell carcinomas from three sisters with a lethal Gorlin-Goltz syndrome.
    Ye L; Wang L; Peng K; Fang O; Tian Z; Li C; Fu X; Chen Q; Chen J; Luan J; Zhang Z; Zhang Q
    BMC Med Genomics; 2022 Aug; 15(1):172. PubMed ID: 35932013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.
    Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L
    Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.